These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 24281041)

  • 21. Telmisartan attenuates monocrotaline-induced pulmonary artery endothelial dysfunction through a PPAR gamma-dependent PI3K/Akt/eNOS pathway.
    Li H; Lu W; Cai WW; Wang PJ; Zhang N; Yu CP; Wang DL; Liu BC; Sun W
    Pulm Pharmacol Ther; 2014 Jun; 28(1):17-24. PubMed ID: 24269521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling.
    Takai S; Kirimura K; Jin D; Muramatsu M; Yoshikawa K; Mino Y; Miyazaki M
    Hypertens Res; 2005 Jul; 28(7):593-600. PubMed ID: 16335888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telmisartan prevented cognitive decline partly due to PPAR-gamma activation.
    Mogi M; Li JM; Tsukuda K; Iwanami J; Min LJ; Sakata A; Fujita T; Iwai M; Horiuchi M
    Biochem Biophys Res Commun; 2008 Oct; 375(3):446-9. PubMed ID: 18715543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TLR4/MyD88/NF-κB signaling and PPAR-γ within the paraventricular nucleus are involved in the effects of telmisartan in hypertension.
    Li HB; Li X; Huo CJ; Su Q; Guo J; Yuan ZY; Zhu GQ; Shi XL; Liu JJ; Kang YM
    Toxicol Appl Pharmacol; 2016 Aug; 305():93-102. PubMed ID: 27292124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma.
    Maejima Y; Okada H; Haraguchi G; Onai Y; Kosuge H; Suzuki J; Isobe M
    Lab Invest; 2011 Jun; 91(6):932-44. PubMed ID: 21403641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of tumor necrosis factor-alpha-induced interleukin-6 expression by telmisartan through cross-talk of peroxisome proliferator-activated receptor-gamma with nuclear factor kappaB and CCAAT/enhancer-binding protein-beta.
    Tian Q; Miyazaki R; Ichiki T; Imayama I; Inanaga K; Ohtsubo H; Yano K; Takeda K; Sunagawa K
    Hypertension; 2009 May; 53(5):798-804. PubMed ID: 19289654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telmisartan improves endothelial dysfunction and renal autoregulation in Dahl salt-sensitive rats.
    Satoh M; Haruna Y; Fujimoto S; Sasaki T; Kashihara N
    Hypertens Res; 2010 Feb; 33(2):135-42. PubMed ID: 19927153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of PPAR-gamma by telmisartan protects the heart against myocardial infarction in experimental diabetes.
    Goyal S; Arora S; Bhatt TK; Das P; Sharma A; Kumari S; Arya DS
    Chem Biol Interact; 2010 May; 185(3):271-80. PubMed ID: 20307515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of vascular angiotensin-converting enzyme by telmisartan via the peroxisome proliferator-activated receptor gamma agonistic property in rats.
    Takai S; Jin D; Kimura M; Kirimura K; Sakonjo H; Tanaka K; Miyazaki M
    Hypertens Res; 2007 Dec; 30(12):1231-7. PubMed ID: 18344629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-γ agonist actions.
    Arozal W; Watanabe K; Veeraveedu PT; Ma M; Thandavarayan RA; Sukumaran V; Suzuki K; Kodama M; Aizawa Y
    Toxicology; 2011 Jan; 279(1-3):91-9. PubMed ID: 20888384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to peroxisome proliferator-activated receptor-gamma activation in mice with chronic cerebral hypoperfusion.
    Washida K; Ihara M; Nishio K; Fujita Y; Maki T; Yamada M; Takahashi J; Wu X; Kihara T; Ito H; Tomimoto H; Takahashi R
    Stroke; 2010 Aug; 41(8):1798-806. PubMed ID: 20595663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin AT1 receptor antagonists exert anti-inflammatory effects in spontaneously hypertensive rats.
    Dai Q; Xu M; Yao M; Sun B
    Br J Pharmacol; 2007 Dec; 152(7):1042-8. PubMed ID: 17922026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of telmisartan on nitric oxide--asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor gamma and peroxisome proliferator activated receptor gamma signaling during endothelial aging.
    Scalera F; Martens-Lobenhoffer J; Bukowska A; Lendeckel U; Täger M; Bode-Böger SM
    Hypertension; 2008 Mar; 51(3):696-703. PubMed ID: 18250362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of cardiovascular cell proliferation by angiotensin receptor blockers: are all molecules the same?
    Benson SC; Iguchi R; Ho CI; Yamamoto K; Kurtz TW
    J Hypertens; 2008 May; 26(5):973-80. PubMed ID: 18398340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adiponectin elevation by telmisartan ameliorates ischaemic myocardium in Zucker diabetic fatty rats with metabolic syndrome.
    Rinaldi B; Di Filippo C; Capuano A; Donniacuo M; Sodano L; Ferraraccio F; Rossi F; D'Amico M
    Diabetes Obes Metab; 2012 Apr; 14(4):320-8. PubMed ID: 22050607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct properties of telmisartan on agonistic activities for peroxisome proliferator-activated receptor γ among clinically used angiotensin II receptor blockers: drug-target interaction analyses.
    Kakuta H; Kurosaki E; Niimi T; Gato K; Kawasaki Y; Suwa A; Honbou K; Yamaguchi T; Okumura H; Sanagi M; Tomura Y; Orita M; Yonemoto T; Masuzaki H
    J Pharmacol Exp Ther; 2014 Apr; 349(1):10-20. PubMed ID: 24424487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Administration of telmisartan reduced systolic blood pressure and oxidative stress probably through the activation of PI3K/Akt/eNOS pathway and NO release in spontaneously hypertensive rats.
    Xu L; Liu Y
    Physiol Res; 2013; 62(4):351-9. PubMed ID: 23590610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telmisartan exerts antiatherosclerotic effects by activating peroxisome proliferator-activated receptor-γ in macrophages.
    Matsumura T; Kinoshita H; Ishii N; Fukuda K; Motoshima H; Senokuchi T; Taketa K; Kawasaki S; Nishimaki-Mogami T; Kawada T; Nishikawa T; Araki E
    Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1268-75. PubMed ID: 21474824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients.
    Vecchiet J; Ucciferri C; Falasca K; Mancino P; Di Iorio A; De Caterina R
    Antivir Ther; 2011; 16(5):639-45. PubMed ID: 21817185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease.
    Garrido-Gil P; Joglar B; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
    J Neuroinflammation; 2012 Feb; 9():38. PubMed ID: 22356806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.